KRTX

Karuna Therapeutics, Inc.

No insider bought or sold Karuna Therapeutics, Inc. in the last 12 months

$0Bought, 12 mo

$0Sold, 12 mo

Follow KRTX

KRTX over the last year

Prices for KRTX aren't in yet.

KRTX after insider buys

3 months after each buy, from the first price a copier could get.

No buys have 3 months of prices yet. A record shows here at 3.

Every filing

128 insider filings since 2019, newest first

KRTXSell

Stephen K. Brannan · Chief Medical Officer

$1.6M−11.0%Mar 11

KRTXSell

Stephen K. Brannan · Chief Medical Officer

$1.6M−11.0%Feb 12

KRTXSell

Stephen K. Brannan · Chief Medical Officer

$4.8M−28.0%Jan 9

KRTXSell

Stephen K. Brannan · Chief Medical Officer

$2.0M−22.0%Dec 12

KRTXSell

Stephen K. Brannan · Chief Medical Officer

$889K−13.0%Nov 13

KRTXSell

Stephen K. Brannan · Chief Medical Officer

$866K−14.0%Oct 10

KRTXSell

Stephen K. Brannan · Chief Medical Officer

$920K−15.0%Sep 11

KRTXSell

Jeffrey M Jonas · Director

$2.6M−93.0%Sep 5

KRTXSell

Troy A. Ignelzi · CFO

$263K−5.0%Aug 24

KRTXSell

Stephen K. Brannan · Chief Medical Officer

$902K−16.0%Aug 10

KRTXSell

Jeffrey M Jonas · Director

$2.7M−93.0%Aug 2

KRTXSell

Laurie J Olson · Director

$216K−50.0%Jul 5

KRTXSell

Jeffrey M Jonas · Director

$3.0M−93.0%Jul 5

KRTXSell

Troy A. Ignelzi · CFO

$2.0M−23.0%May 25

KRTXSell

Andrew Craig Miller · COO

$9.0M−65.0%Apr 20

KRTXSell

Stephen K. Brannan · Chief Medical Officer

$884K−17.0%Apr 12

KRTXSell

Laurie J Olson · Director

$181K−100.0%Apr 5

KRTXSell

Stephen K. Brannan · Chief Medical Officer

$948K−17.0%Mar 9

KRTXSell

Troy A. Ignelzi · CFO

$1.1M−16.0%Feb 23

KRTXSell

Stephen K. Brannan · Chief Medical Officer

$962K−17.0%Feb 13

KRTXSell

Troy A. Ignelzi · CFO

$205K−4.0%Jan 19

KRTXSell

James Healy · Director

$1.2MJan 17

KRTXSell

Stephen K. Brannan · Chief Medical Officer

$988K−25.0%Jan 9

KRTXSell

Laurie J Olson · Director

$197K−100.0%Jan 5

KRTXSell

Stephen K. Brannan · Chief Medical Officer

$1.0M−25.0%Dec 12

KRTXSell

Andrew Craig Miller · COO

$3.4M−57.0%Dec 2

KRTXSell

Troy A. Ignelzi · CFO

$3.7M−62.0%Nov 17

KRTXSell

Andrew Craig Miller · COO

$3.4M−37.0%Nov 14

KRTXSell

Stephen K. Brannan · Chief Medical Officer

$1.1M−25.0%Nov 10

KRTXSell

Andrew Craig Miller · COO

$3.4M−28.0%Nov 3

KRTXSell

Stephen K. Brannan · Chief Medical Officer

$1.0M−25.0%Oct 12

KRTXSell

Laurie J Olson · Director

$206K−100.0%Oct 12

KRTXSell

Troy A. Ignelzi · CFO

$3.4M−60.0%Oct 4

KRTXSell

Stephen K. Brannan · Chief Medical Officer

$1.2M−25.0%Sep 12

KRTXSell

Laurie J Olson · Director

$268K−100.0%Aug 16

KRTXSell

Troy A. Ignelzi · CFO

$3.8M−40.0%Aug 11

KRTXSell

Stephen K. Brannan · Chief Medical Officer

$5.7M−63.0%Aug 11

KRTXSell

Stephen K. Brannan · Chief Medical Officer

$2.0M−50.0%Jul 11

KRTXBuy

James Healy · Director

$14.7M+6.0%Jul 1

KRTXSell

Stephen K. Brannan · Chief Medical Officer

$555K−25.0%Jun 9

KRTXSell

Laurie J Olson · Director

$110K−100.0%May 31

KRTXSell

Stephen K. Brannan · Chief Medical Officer

$521K−25.0%May 9

KRTXSell

Troy A. Ignelzi · CFO

$557K−15.0%Apr 21

KRTXSell

Stephen K. Brannan · Chief Medical Officer

$993K−34.0%Apr 4

KRTXSell

Stephen K. Brannan · Chief Medical Officer

$830K−38.0%Mar 2

KRTXSell

Troy A. Ignelzi · CFO

$167K−6.0%Feb 17

KRTXSell

Laurie J Olson · Director

$110K−100.0%Feb 17

KRTXSell

Atul Pande · Director

$277K−100.0%Feb 2

KRTXSell

Stephen K. Brannan · Chief Medical Officer

$850K−44.0%Feb 2

KRTXSell

Atul Pande · Director

$326K−100.0%Jan 3

Older filings

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.